Services

Seven disciplines. One accountable team.

Everything it takes to move a molecule from discovery to market, held by one team that answers for the whole journey. No handoffs. No gaps.
01
Development to launch (D2L)
CMC & Product Development
End-to-end CMC and formulation expertise, from first-in-human clinical development to commercial supply, for NCEs, 505(b)(2)s and generics.
Explore
02
Discovery to IND
Drug Discovery & NCE Development
Flexible, cost-effective discovery and early development chemistry, from hit finding through the IND data package.
Explore
03
Clinical strategy and oversight
Clinical CRO & Bioequivalence
Clinical and bioequivalence strategy with hands-on CRO oversight, from study design to clinical supply.
Explore
04
Strategy and filings, full lifecycle
Regulatory Affairs
Regulatory strategy and compliant submissions across the US, Canada and EU, from IND to post-approval.
Explore
05
Audit-ready quality systems
Quality & Compliance
GMP quality systems built, assessed and strengthened to withstand regulatory scrutiny across FDA, WHO, EU and PIC/S.
Explore
06
Senior leadership, when and where needed
Strategic Advisory & Fractional Leadership
Senior regulatory, quality and CMC leadership on a fractional basis. Portfolio strategy and M&A due-diligence including site and financial assessments.
Explore
07
Alliance and program delivery
CDMO and Testing & Certification (TIC) Management
Experts in the CDMO and TIC industry: select the right partners, negotiate contracts and drive profitability.
Explore
08
Methods that hold up under review
Analytical Development & Validation
Phase-appropriate analytical method development, validation and transfer, with the stability programs and specifications that carry a dossier through review.
Explore
Not sure which discipline your program needs? Start with the problem, and we will map the rest.
Request a consultation
Credence
Pharma
Credible partners for pharmaceutical & life-sciences clients. Evidence-led advisory in CMC, regulatory, quality and strategy for NCEs, generics and branded-generics.
© 2026 Credence Pharma Consulting Inc. All rights reserved.